
Does ivermectin treat neuroendocrine tumours?
Checked
Posts say that ivermectin, a drug normally used against parasites, can treat neuroendocrine tumours.
We found no study showing that ivermectin treats neuroendocrine tumours.
What studies show
As of , we found no study on ivermectin and neuroendocrine tumours. We found 2 published papers on ivermectin and neuroendocrine tumours. They were published between 2019 and 2022. From their records, none of them is a study in people. 1 was a study in animals, and none was only in cells in the lab.
In animals
A 2022 study gave ivermectin to mice with melanoma, a skin cancer. Melanoma is not a neuroendocrine tumour. The drug did not slow the growth of the tumour itself. It did reduce how much the cancer spread to the lungs. Results in animals do not always hold in people.
Other papers
A 2019 safety bulletin lists a severe skin reaction to ivermectin. The same bulletin does not report any test of ivermectin against neuroendocrine tumours.
What this means for you
Our verdict: Unproven.
No study in people has tested ivermectin for neuroendocrine tumours. The one animal study looked at a different cancer and found no effect on tumour growth, so the claim is unproven.
Do not stop or change your treatment because of a story about ivermectin. No study we found shows whether it helps. If you are thinking about ivermectin, talk to your care team first.
This page explains what research has found so far. It is not medical advice. Talk to your doctor before you start, stop or change any treatment.
We searched 18 scientific databases for research from the last 10 years (since 17 Nov 2016).
Sources
- Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis. Front Oncol 2022. In animals. PubMed
- ISMP Adverse Drug Reactions: Pheochromocytoma Crisis Induced by Metoclopramide Baclofen Dependence Following High-Dose Therapy Fatal Cardiotoxicity Following High-Dose Cyclophosphamide Acute Anterograde Amnestic Syndrome Induced by Fentanyl Ivermectin-Induced Toxic Epidermal Necrolysis Pembrolizumab-Induced Type 1 Diabetes. Hosp Pharm 2019. Other paper. PubMed
Frontlight Community
Share what you saw, tried or were told about this claim, and read what others went through. Posts are not medical advice: ask your doctor about your own treatment.
Be the first to share your experience or your question about this claim
You need a Frontlight account with a verified e-mail address to comment.